TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 4 | 10 | 27 | 15 | 72 | 219 | 58 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/17 17:33 | 3/10/17 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MI | D | P.d | 500 | 9.47 | 0 | 53 | 7 | 859 | I | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | ||||||
8/12/16 13:09 | 8/10/16 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MI | D | P.d | 5,000 | 10.00 | 0 | 500 | 163 | 806 | I | 0 | 7 | 13 | 39 | 4 | 14 | |||||||||
5/21/14 17:26 | 5/19/14 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MA | D | P | 231 | 9.24 | 2 | 25 | 2 | 1,494 | D | 16 | -20 | -33 | -16 | -14 | 0 | 8 | 5 | 13 | 38 | 28 | 143 | 387 | ||
3/27/13 20:05 | 3/25/13 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MA | DT | P.d | 3,473 | 7.00 | 3 | 496 | 51 | 1,469 | I | -1 | 1 | 2 | 7 | 12 | 60 | 51 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |